NewAmsterdam Pharma Company N.V. (NAMSW) Stock Price & Analysis
NewAmsterdam Pharma Company N.V. (NAMSW) closed at USD 10.95 on Tuesday, October 13, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 10.95; the Oct 13, 2026 session ranged USD 9.79–10.95 on volume of 3 shares. Market capitalization is —, with a 52-week range of USD 9.79–30.45 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/NAMSW.md
Key facts (NAMSW)
- Total return with dividends: 1Y -56.2% vs S&P 500 +18.1%; 5Y +1695.1% vs S&P 500 +85.1%.
Total return (dividends reinvested) (NAMSW)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -56.2% | +1695.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -56.3% | +78.0% |
| Volatility (annualized) | 86.9% | 142.3% |
| Max drawdown | -63.5% (May 2026→Oct 2026) | -92.6% (Nov 2021→Jun 2022) |
Key Statistics (as of October 16, 2026 at 05:49 UTC)
| Price | USD 10.95 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.95 |
| Open | USD 10.95 |
| Day Range | USD 9.79 – 10.95 |
| 52-Week Range | USD 9.79 – 30.45 |
| Volume | 3 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (NAMSW)
Nexqual's technical model rates NAMSW "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 19.2 (oversold) |
| vs SMA50 | Below (USD 13.68) |
| MACD | -0.74 (negative) |
Earnings (NAMSW)
| Revenue Estimate | $6.41M |
|---|
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financials & Fundamentals (NAMSW)
| Total Revenue | $7.12M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -80.70% |
| Gross Margin | +100.00% |
| Operating Margin | -1752.61% |
| Profit Margin | +0.00% |
| ROE | -36.81% |
| Debt / Equity | 0 |
| Current Ratio | 9.03 |
| Total Cash | $633.85M |
| Total Debt | $82,000 |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Ownership (NAMSW)
| Float | 81.50M |
|---|
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Leadership (NAMSW)
NewAmsterdam Pharma Company N.V. is led by Michael Harvey Davidson FACC, Facp. (age 69), CEO, President & Executive Director, per Nexqual as of October 16, 2026 at 05:49 UTC.
| CEO, President & Executive Director | Michael Harvey Davidson FACC, Facp. (age 69) |
|---|---|
| Founder, Chief Scientific Officer, Member of Executive Board & Director | Johannes Jacob Pieter Kastelein FESC (age 71) |
| Chief Financial Officer | Mayur Amrat Somaiya (age 51) |
| Executive Vice President of Sales Enterprise Operations | Chris Deluzio |
| Chief Strategy & Business Officer | Juliette Audet M.B.A., M.Sc. (age 38) |
Major Backers & Investors (NAMSW)
Notable institutional backers of NewAmsterdam Pharma Company N.V. include Frazier Life Sciences Management, L.P. , RA Capital Management, L.P., Affinity Asset Advisors, Llc, according to Nexqual as of October 16, 2026 at 05:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Frazier Life Sciences Management, L.P. | 10.88% |
| RA Capital Management, L.P. | 7.25% |
| Affinity Asset Advisors, Llc | 5.33% |
| Bain Capital Life Sciences Investors, LLC | 2.17% |
| Deerfield Management Company, L.P | 2.02% |
| Aristeia Capital, LLC | 0.34% |
| Wolverine Asset Management, LLC | 0.32% |
| Vestcor Inc | 0.14% |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NAMS | NewAmsterdam Pharma Company N.V | USD 20.62 | ▲ 2.13% |
| MLECW | Moolec Science SA Warrant | USD 0.01 | ▲ 20% |
| REVBW | Revelation Biosciences, Inc. | USD 0.01 | ▲ 1.56% |
| HUMAW | Humacyte, Inc. | USD 0 | ▼ 78.05% |
| OCSAW | Oculis Holding AG Warrants | USD 2.6 | ▲ 4.42% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt